Prospective study of tace combined with sorafenib vs tace combined with 125i seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas

HIGHLIGHTS

• who: Xiao-Hui Zhao from the Sun Yat-sen University Cancer Center (SYSUCC), China have published the paper: Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas, in the Journal: (JOURNAL) of 31/Dec/2020
• what: The aims were to evaluate the improvement rates of APFs, changes in liver function indices, and DCR of intrahepatic lesions and PVTT after the first TACE. In terms of related indicators before and after treatment, the results of this study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.